Who Paid My Doc
Angela Gray
Nurse Practitioner, Family Peoria, IL Nurse Practitioner
NPI 1952027518 CMS profile 11392589
530 Ne Glen Oak Ave, Peoria, IL 61637
General payments
$275
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Angela Gray of Peoria, IL is reported in the CMS Open Payments database as having received $275 across 11 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 47th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $259 | 10 | |
| 2024 | General | $15 | 1 |
Beside peers
- Angela Gray
- Nurse Practitioner, Family median
- Middle half of Nurse Practitioner, Family
- National median
In program year 2025, general payments to Angela Gray were reported at $259. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.
Show as a table
| Year | Angela Gray | Nurse Practitioner, Family median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $39 | $18–$91 | $163 |
| 2020 | $0 | $32 | $17–$76 | $114 |
| 2021 | $0 | $124 | $35–$379 | $132 |
| 2022 | $0 | $141 | $44–$430 | $149 |
| 2023 | $0 | $154 | $49–$476 | $160 |
| 2024 | $15 | $165 | $51–$504 | $164 |
| 2025 | $259 | $168 | $53–$521 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$7,641
Medicare patients
126
Services billed
143
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 44% | |
| Chronic kidney disease | 43% | |
| Ischemic heart disease | 40% | |
| COPD | 38% | |
| Heart failure | 35% | |
| Diabetes | 33% | |
| Atrial fibrillation | 31% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Family in Illinois
Ruth Carrico
Nurse Practitioner, Family · Chicago, IL
Aleksandra Bielawiec
Nurse Practitioner, Family · Barrington, IL
Erin Sieber
Nurse Practitioner, Family · Naperville, IL
Jamie Brogan
Nurse Practitioner, Family · Chicago, IL
Ashley Noeth
Nurse Practitioner, Family · Glen Carbon, IL
Marita Kametas
Nurse Practitioner, Family · Chicago, IL
Related records
Nurse Practitioner, Family in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Family
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.